Lifeedit, Inc.
Records under this name other than the patents Lifeedit, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 17 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| 17/045,053 | Methods and Compositions to Identify Novel CRISPR Systems Abandoned Abandoned Jun 16, 2023 | Abandoned | Abandoned Jun 16, 2023 | |
| 18/005,467 | Uracil Stabilizing Proteins and Active Fragments and Variants Thereof and Methods of Use held by Lifeedit Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/447,947 | RNA-Guided Nucleases and Active Fragments and Variants Thereof and Methods of Use held by Lifeedit Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/826,746 | Polypeptides Useful for Gene Editing and Methods of Use held by LifeEDIT Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/852,277 | Compositions and Methods for the Treatment of Huntingtons Disease by Editing the Mutant Huntingtin Gene held by Life Edit Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/946,402 | Nucleic Acid Molecules Encoding DNA Modifying Enzymes and Active Fragments and Variants Thereof and Compositions Comprising the Same held by Life Edit Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/955,480 | Nucleic Acid Molecules Encoding DNA Modifying Enzymes and Active Fragments and Variants Thereof and Compositions Comprising the Same held by Life Edit Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/960,883 | Polypeptides Useful for Gene Editing and Methods of Use held by Life Edit Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/052,482 | RNA-Guided Nucleases and Active Fragments and Variants Thereof and Methods of Use held by Life Edit Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/055,281 | DNA Modifying Enzymes and Active Fragments and Variants Thereof and Methods of Use held by Life Edit Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |